We are live on ! Find out more
PASW

Ping An Biomedical

4 hedge funds and large institutions have $49.4K invested in Ping An Biomedical in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital invested

Capital invested by funds: $31.4K → $49.4K (+$18K)

0.29% more ownership

Funds ownership: 1.16%1.46% (+0.29%)

0% more funds holding

Funds holding: 44 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

PASW Hedge Fund Activity: Q2 2026 in Review

4 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Ping An Biomedical (PASW) for Q2 2026, worth a combined $49.4K — up 57% from $31.4K a quarter earlier.

Fund positioning in PASW was balanced in Q2 2026: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $18.4K. The largest seller was Jane Street, exiting entirely with an estimated $6.93K sold.

  • 4 institutional investors held Ping An Biomedical (PASW) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $49.4K of Ping An Biomedical stock for Q2 2026, up 57% quarter-over-quarter.
  • 2 funds opened new Ping An Biomedical positions in Q2 2026 and 2 closed out, a net change of 0 holders.
  • The largest Ping An Biomedical buyer in Q2 2026 was Citadel Advisors, an estimated $18.4K added.
  • The largest Ping An Biomedical seller in Q2 2026 was Jane Street, an estimated $6.93K sold.

Based on aggregated 13F filings for Q2 2026.